Genmab — December 2018
-
Bikuben man er nød til at sammenholde antal arbejdsdage, samt med det faktum at der var nedgang i salget i sidste mrd i dag/dag salget. 122 er også mere at betragte som en linje under er skidt over er godkendt. Vi kan jo håbe at der har været lidt off-label salg på bagrund af maia.
-
Vestas, Novo og Genmab er inde i varmen igen: https://penge.borsen.dk/artikel/1/374101/disse_tre_danske_aktier_har_for_foerste_gang_i_lang_tid_genvundet_momentum.html?utm_source=forside&utm_campaign=nyhed_04
-
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind